ZA9610510B - Novel peptides, the preparation and use thereof. - Google Patents

Novel peptides, the preparation and use thereof.

Info

Publication number
ZA9610510B
ZA9610510B ZA9610510A ZA9610510A ZA9610510B ZA 9610510 B ZA9610510 B ZA 9610510B ZA 9610510 A ZA9610510 A ZA 9610510A ZA 9610510 A ZA9610510 A ZA 9610510A ZA 9610510 B ZA9610510 B ZA 9610510B
Authority
ZA
South Africa
Prior art keywords
preparation
novel peptides
peptides
novel
Prior art date
Application number
ZA9610510A
Other languages
English (en)
Inventor
Wilhelm Amberg
Teresa Barlozzari
Harald Bernard
Ernst Buschmann
Andreas Haupt
Hans-Guenter Hege
Bernd Janssen
Andreas Kling
Helmut Lietz
Kurt Ritter
Martina Ullrich
Juergen Weymann
Thomas Zierke
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of ZA9610510B publication Critical patent/ZA9610510B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/10—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using coupling agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9610510A 1995-12-15 1996-12-13 Novel peptides, the preparation and use thereof. ZA9610510B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57342295A 1995-12-15 1995-12-15

Publications (1)

Publication Number Publication Date
ZA9610510B true ZA9610510B (en) 1998-06-15

Family

ID=24291935

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9610510A ZA9610510B (en) 1995-12-15 1996-12-13 Novel peptides, the preparation and use thereof.

Country Status (30)

Country Link
EP (2) EP1593686B1 (xx)
JP (1) JP3939354B2 (xx)
KR (1) KR100463739B1 (xx)
CN (1) CN1127514C (xx)
AR (1) AR004382A1 (xx)
AT (2) ATE471944T1 (xx)
AU (2) AU731458B2 (xx)
BG (1) BG64563B1 (xx)
BR (1) BR9611987A (xx)
CA (1) CA2237721C (xx)
CO (1) CO4750840A1 (xx)
CZ (1) CZ296908B6 (xx)
DE (2) DE69633457T2 (xx)
DK (1) DK0866800T3 (xx)
ES (1) ES2229287T3 (xx)
HR (1) HRP960585A2 (xx)
HU (1) HU228275B1 (xx)
IL (2) IL124342A (xx)
MX (1) MX9803953A (xx)
MY (1) MY114327A (xx)
NO (1) NO319273B1 (xx)
NZ (1) NZ324691A (xx)
PL (1) PL186721B1 (xx)
PT (1) PT866800E (xx)
RU (1) RU2182911C2 (xx)
SK (1) SK285286B6 (xx)
TR (1) TR199801102T2 (xx)
TW (1) TW474946B (xx)
WO (1) WO1997022621A2 (xx)
ZA (1) ZA9610510B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143721A (en) * 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
US5985837A (en) * 1998-07-08 1999-11-16 Basf Aktiengesellschaft Dolastatin 15 derivatives
WO2000051998A1 (en) 1999-03-02 2000-09-08 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cathepsin s
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879276A (en) * 1983-12-19 1989-11-07 Uniroyal Chemical Ltd./Uniroyal Chemical Ltee Method for reducing serum uric acid levels
US4816444A (en) * 1987-07-10 1989-03-28 Arizona Board Of Regents, Arizona State University Cell growth inhibitory substance
HUT71398A (en) * 1992-05-20 1995-11-28 Basf Ag Derivatives of dolastatin
US5831002A (en) * 1992-05-20 1998-11-03 Basf Aktiengesellschaft Antitumor peptides
DE69329425T2 (de) * 1992-12-16 2001-01-18 Basf Ag Dolastatin analog
DE4415998A1 (de) * 1994-05-06 1995-11-09 Basf Ag Neue Tetrapeptide, ihre Herstellung Verwendung
DE4415997A1 (de) * 1994-05-06 1995-11-09 Basf Ag Neuer peptidischer Wirkstoff und dessen Herstellung
US5807984A (en) * 1995-11-09 1998-09-15 Basf Aktienegesellschaft Oligopeptides, the preparation and use thereof

Also Published As

Publication number Publication date
SK76798A3 (en) 1999-02-11
AR004382A1 (es) 1998-11-04
WO1997022621A2 (en) 1997-06-26
TW474946B (en) 2002-02-01
ATE277076T1 (de) 2004-10-15
DE69638206D1 (de) 2010-08-05
IL124342A (en) 2005-06-19
CA2237721C (en) 2008-01-29
NO319273B1 (no) 2005-07-11
KR20000064400A (ko) 2000-11-06
CN1204342A (zh) 1999-01-06
NO982711D0 (no) 1998-06-12
AU731458B2 (en) 2001-03-29
EP0866800A2 (en) 1998-09-30
NZ324691A (en) 1999-11-29
PT866800E (pt) 2005-01-31
KR100463739B1 (ko) 2005-02-28
IL124342A0 (en) 1998-12-06
CZ184698A3 (cs) 1998-09-16
SK285286B6 (sk) 2006-10-05
BG102479A (en) 1999-06-30
BG64563B1 (bg) 2005-07-29
CZ296908B6 (cs) 2006-07-12
AU1192597A (en) 1997-07-14
MX9803953A (es) 1998-09-30
EP0866800B1 (en) 2004-09-22
HU228275B1 (en) 2013-02-28
NO982711L (no) 1998-06-12
MY114327A (en) 2002-09-30
JP2000502092A (ja) 2000-02-22
DK0866800T3 (da) 2005-01-17
ATE471944T1 (de) 2010-07-15
ES2229287T3 (es) 2005-04-16
TR199801102T2 (xx) 1998-12-21
PL186721B1 (pl) 2004-02-27
PL327175A1 (en) 1998-11-23
HUP0000172A3 (en) 2000-09-28
WO1997022621A3 (en) 1998-02-26
JP3939354B2 (ja) 2007-07-04
DE69633457T2 (de) 2005-09-22
DE69633457D1 (de) 2004-10-28
EP1593686B1 (en) 2010-06-23
AU2004220772B2 (en) 2008-06-12
BR9611987A (pt) 1999-02-17
CN1127514C (zh) 2003-11-12
CO4750840A1 (es) 1999-03-31
HRP960585A2 (en) 1998-02-28
AU2004220772A1 (en) 2004-11-11
RU2182911C2 (ru) 2002-05-27
CA2237721A1 (en) 1997-06-26
HUP0000172A2 (en) 2000-07-28
IL166853A (en) 2013-03-24
EP1593686A1 (en) 2005-11-09

Similar Documents

Publication Publication Date Title
ZA964710B (en) Novel compounds, the preparation and use thereof.
HUP9802217A3 (en) Recombinant mva virus, and the use thereof
ZA972727B (en) A novel composition, its preparation and use.
HK1018780A1 (en) 6-Phenylpyridine-2-ylamine derivatives, the composition and use thereof.
HUP9801570A3 (en) Polysiloxane-comprising perfluoroalkyl ethers, and the preparation and use thereof
EP0674898A3 (en) Shampoo composition.
ZA966075B (en) Protein formulation.
SI1019358T1 (en) 3,3-diarylpropylamines , their use and preparation
AU6636598A (en) Novel 3,4-dialkoxyphenyl derivatives and the use thereof
ZA965418B (en) Quick-fermented feed, its preparation and uses.
ZA966676B (en) Bacteriocin.
HK1001404A1 (en) Isolated, tyrosinase derived peptides and uses thereof.
ZA959630B (en) Diaminocyclobutene-3, 4-diones.
ZA9610278B (en) Pyridylcarbamates, processes and intermediates for their preparation, and their use.
HK1020739A1 (en) Novel lantibiotic related to actagardine, and processes for the preparation and use thereof.
EP0978524A4 (en) FLUOROPOLYMERS, METHOD FOR THEIR PRODUCTION AND THEIR USE
ZA969402B (en) Novel oligopeptides, the preparation and use thereof.
AU1441195A (en) Phenylmethyl hexanamides, and the use thereof
ZA976479B (en) Alfa-amino acids amides, preparation thereof and the therapeutical use thereof.
EP0650522A4 (en) NOVEL CYCLOPHILINES, PROTEINS ASSOCIATED WITH THESE CYCLOPHILINES AND THEIR USES.
EP0679658A4 (en) PEPTIDE WITH ANTAGONIST EFFECT OF ENDOTHELIN.
ZA9810625B (en) Benzylidenepyrazolones, their preparation and use.
ZA963620B (en) (Het)aryloxy-, -thio- and -aminocrotonates, their preparation and their use.
AU5557698A (en) Novel calpaines, their preparation and use
ZA9610510B (en) Novel peptides, the preparation and use thereof.